CN1080863A - A kind of anti-alcoholic health care medicinal composition - Google Patents
A kind of anti-alcoholic health care medicinal composition Download PDFInfo
- Publication number
- CN1080863A CN1080863A CN 93107382 CN93107382A CN1080863A CN 1080863 A CN1080863 A CN 1080863A CN 93107382 CN93107382 CN 93107382 CN 93107382 A CN93107382 A CN 93107382A CN 1080863 A CN1080863 A CN 1080863A
- Authority
- CN
- China
- Prior art keywords
- add
- preparation
- ginseng stem
- leaf
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 9
- 230000002075 anti-alcohol Effects 0.000 title description 8
- 241000208340 Araliaceae Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 229930182490 saponin Natural products 0.000 claims abstract description 14
- 150000007949 saponins Chemical class 0.000 claims abstract description 14
- 235000017709 saponins Nutrition 0.000 claims abstract description 14
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 10
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 206010019133 Hangover Diseases 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000008187 granular material Substances 0.000 claims abstract 2
- 239000003826 tablet Substances 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229920002472 Starch Polymers 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 5
- 244000184734 Pyrus japonica Species 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229930182494 ginsenoside Natural products 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 229940089161 ginsenoside Drugs 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 2
- 235000013616 tea Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 16
- 239000003814 drug Substances 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种解酒的药物组合物,它由葛 花、青皮和人参茎叶皂甙组成,具有解酒保健功效,可 以制成胶囊剂、片剂、冲剂、茶剂、口服液。The invention discloses a medicinal composition for hangover, which consists of kudzu Composed of flowers, green bark and ginseng stem and leaf saponins, it has the effect of hangover health care, and can To make capsules, tablets, granules, teas, oral liquids.
Description
本发明是一种解酒的药物,它是一种以中草药为原料,经特定加工工艺制成的中药制剂,具有解酒,保健功效,属于中药制剂领域。The invention relates to a medicine for hangover, which is a traditional Chinese medicine preparation made by using Chinese herbal medicine as a raw material through a specific processing technology.
饮酒是多数的人一种嗜好,但是过量饮酒会对人体带来严重的损伤。酒进入人体后,酒精被吸收入血,随饮酒量的增加血中酒精浓度也相应增加,当血中酒精浓度达到0.5%以上时,可出现高度抑制、昏睡、意识障碍、大小便失禁,如不进行及时抢救,可因呼吸麻痹而死亡。因此对于饮酒过度的人来说,非常需要有一种解酒药物来缓解和治疗其酒精中毒。目前临床上尚没有一种疗效确切的解酒药供医生选择使用。Drinking alcohol is a hobby of most people, but excessive drinking can cause serious damage to the human body. After alcohol enters the human body, the alcohol is absorbed into the blood, and the alcohol concentration in the blood also increases correspondingly with the increase of the amount of drinking. When the alcohol concentration in the blood reaches more than 0.5%, high depression, drowsiness, disturbance of consciousness, and incontinence may occur, such as If timely rescue is not carried out, death may occur due to respiratory paralysis. Therefore for people who drink excessively, it is very necessary to have a kind of anti-alcoholic medicine to alleviate and treat its alcoholism. At present, there is not yet a kind of definite anti-alcoholic medicine for doctors to choose and use clinically.
本发明目的是提供一种解酒药物制剂。The object of the present invention is to provide a drug preparation for anti-alcoholism.
本发明的另一个目的是提供上述解酒制剂的加工工艺。Another object of the present invention is to provide a processing technology for the above-mentioned anti-alcohol preparation.
本发明解酒药剂的组方及制备过程如下:The prescription and the preparation process of the anti-alcoholic medicament of the present invention are as follows:
处方组成:葛花、青皮、人参茎叶皂甙。Prescription composition: kudzu flower, green bark, ginseng stem and leaf saponin.
上述处方中各组份的用量比为(重量比):The consumption ratio of each component in the above-mentioned prescription is (weight ratio):
葛花∶青皮∶人参茎叶皂甙=25-35∶5-15∶0.5-2。Pueraria japonica: green bark: ginseng stem and leaf saponin=25-35:5-15:0.5-2.
各组份之间的最佳重量比为:The optimal weight ratio between each component is:
葛花∶青皮∶人参茎叶皂甙=30∶10∶1。Pueraria japonica: green bark: ginseng stem and leaf saponins = 30:10:1.
上述处方中使用的人参茎叶皂甙是从人参茎叶中提取的呈浅棕色粉末,具有吸湿性的皂甙提取物〔参见:《药学学报》1983年第18卷第10期〕。本发明使用的人参茎叶皂甙应符合辽卫药准字(84)942-66号《关于人参皂甙暂行质量标准的批复》批文的质量要求。The ginseng stem and leaf saponin used in the above prescription is a light brown powder extracted from the ginseng stem and leaf, and is a saponin extract with hygroscopicity [refer to: "Acta Pharmacologica" 1983, Volume 18, No. 10]. The ginseng stem and leaf saponins used in the present invention should meet the quality requirements of the approval document No. (84) 942-66 "Reply on Interim Quality Standards for Ginsenosides".
在实际制剂过程中,上述处方还可加入常规的药物赋形剂,如淀粉、糊精等。赋形剂的加入量对于药效的影响并不是至关重要的,本领域中的技术人员可根据实际需要而选择其常用量。In the actual preparation process, conventional pharmaceutical excipients, such as starch and dextrin, can also be added to the above prescription. The amount of excipients added is not critical to the effect of the drug, and those skilled in the art can choose the usual amount according to actual needs.
上述的药物组合物可以制备成不同的剂型,如冲剂、茶剂、片剂、胶囊剂、口服液等。The above-mentioned pharmaceutical composition can be prepared into different dosage forms, such as electuary, tea, tablet, capsule, oral liquid and the like.
现结合胶囊剂型说明其加工工艺过程。Now combine the capsule dosage form to illustrate its processing technology.
二、制备工艺2. Preparation process
(一)工艺流程(1) Process flow
原料→煎煮→过滤→浓缩→加入人参皂甙→干燥→粉碎→过筛→加适量淀粉混匀→装胶囊→包装。Raw materials→decocting→filtering→concentrating→adding ginsenosides→drying→crushing→sieving→adding appropriate amount of starch and mixing→filling in capsules→packing.
(二)操作过程(2) Operation process
按处方组成中的原料量,称取葛花和青皮用12倍水润湿后加热煮沸1小时沙布过滤。药渣再加入7-8倍水煮沸40分钟,按上法过滤。合并滤液,减压浓缩至稀糊状,加入处方量人参茎叶皂甙,60-80℃下减压干燥。干燥物粉碎后过80目筛,干粉加适量淀粉混匀装入胶囊中,囊心物均在0.48克左右。According to the amount of raw materials in the composition of the prescription, weigh Pueraria japonica and Qingpi, moisten with 12 times of water, heat and boil for 1 hour and filter with gauze. Add 7-8 times of water to the dregs, boil for 40 minutes, and filter according to the above method. Combine the filtrates, concentrate under reduced pressure to a thin paste, add the prescribed amount of ginseng stem and leaf saponins, and dry under reduced pressure at 60-80°C. The dry matter is crushed and passed through an 80-mesh sieve, and the dry powder is mixed with an appropriate amount of starch and packed into capsules, and the capsule core is about 0.48 grams.
(三)工艺说明(3) Process Description
1.用煎煮法进行提取的依据1. The basis for extraction by decoction
本方中葛花为君药。葛花中的主要醒酒有效成份为水溶性成份,故用水煎法可以更好的发挥药效。青皮中的主要有效成份为黄酮甙类化合物,在热水中也有较好的溶解度,故本处方的提取采用水煎法。In this prescription, Pueraria lobata is the monarch drug. The main sobering active ingredients in kudzu flower are water-soluble ingredients, so decoction with water can better exert the medicinal effect. The main active ingredients in Qingpi are flavonoid glycosides, which also have good solubility in hot water, so the extraction of this prescription adopts the water decoction method.
2.煎煮时间的考查2. Examination of cooking time
本处方主要成分葛花和青皮,它们均分别含有异黄酮和二氢黄酮,在UV中270nm附近有最大吸收,可以作为主要成分来考查提取工艺。总提取物的UV吸收光谱见附图。The main ingredients of this prescription are Pueraria japonica and Qingpi. They both contain isoflavones and flavanones respectively, and have the maximum absorption near 270nm in UV, which can be used as the main ingredients to examine the extraction process. The UV absorption spectrum of the total extract is shown in the accompanying drawing.
按处方量投料后共提取三次,从沸腾时间算起每隔20分钟取样,在275nm处测定紫外吸收度,数值见表1及图1。图1为溶出速率曲线。After feeding according to the prescription amount, extract three times in total, take samples every 20 minutes from the boiling time, and measure the UV absorbance at 275nm, the values are shown in Table 1 and Figure 1. Figure 1 is the dissolution rate curve.
表1提取次数及提取百分率的实验结果The experimental result of table 1 extraction number of times and extraction percentage
结论 从上表及图示的实验结果可以得出下列结论:Conclusion The following conclusions can be drawn from the experimental results in the above table and diagrams:
(1)、第一次煎煮提取时以1小时为宜。因为在第一次提取时吸收度在60分钟已达到平衡不再升高,说明已达到最大提取率,应重新更新溶剂。(1) It is advisable to decoct and extract for the first time for 1 hour. Because the absorbance has reached equilibrium in 60 minutes during the first extraction and no longer increases, indicating that the maximum extraction rate has been reached, and the solvent should be renewed.
(2)、第二次煎煮提取时,提取吸收度在40分钟后不再改变,亦说明提取较完全。(2) When decocting and extracting for the second time, the extraction absorbency does not change after 40 minutes, which also shows that the extraction is relatively complete.
3.煎煮次数的决定3. Determination of the number of times of decoction
按处方量投料后共提取三次,测定紫处吸收度。表二所示的吸收度代表提取率。则第一、二、三煎的提取率分别为64.8%、23.9%及11.4%。其中第一、二煎占总提取率的88.7%,已将生药中有效成分绝大部分提取出来,故考虑到成本及能源消耗等诸因素确定只提取两次。After feeding according to the prescription amount, it was extracted three times in total, and the absorbance of purple part was measured. The absorbance shown in Table 2 represents the extraction rate. The extraction rates of the first, second and third decoctions are 64.8%, 23.9% and 11.4% respectively. Among them, the first and second decoctions account for 88.7% of the total extraction rate, and most of the active ingredients in the crude drug have been extracted, so it is determined to only extract twice in consideration of various factors such as cost and energy consumption.
4.出膏率的考查:4. Examination of the ointment rate:
我们共进行了三批原料出膏率的考查,两次提取液浓缩后浸膏收率为17%→20%左右。结果见下表:We conducted a total of three batches of raw materials to examine the yield of the extract, and the yield of the extract was about 17%→20% after the two extractions were concentrated. The results are shown in the table below:
本发明的解酒药物具有良好的解酒、醒酒功能。通过滚棒实验和苏醒试验表明时,本发明药物具有较好的抗急性酒精中毒的能力,并且明显延迟动物开始醉酒的时间,并缩短动物的昏睡时。是一种效果肯定的解酒药。The anti-alcoholic drug of the invention has good anti-alcoholic and sober functions. When it is shown by rolling rod test and recovery test, the medicament of the present invention has better anti-acute alcoholism ability, and obviously delays the time for animals to start getting drunk, and shortens the animals' drowsiness. It is a definite anti-alcoholic medicine.
实施例1Example 1
取葛花1500g,青皮500g,加12倍水浸润后加热煮沸1小时,沙布过滤,药渣再加7-8倍水煮沸40分钟,再用沙布过滤,合并滤液,减压浓缩至稀糊状,加入人参茎叶皂甙50g,60-80℃下减压干燥,干燥物粉碎后过80目筛,加适量淀粉混匀共500g,装入胶囊中,囊物在0.5g左右。Take 1500g of kudzu flower and 500g of green skin, add 12 times of water to infiltrate, heat and boil for 1 hour, filter with gauze, add 7-8 times of water to the dregs and boil for 40 minutes, then filter with gauze, combine the filtrates, concentrate under reduced pressure to dilute Paste, add 50g of ginseng stem and leaf saponins, dry under reduced pressure at 60-80°C, crush the dry matter and pass through an 80-mesh sieve, add an appropriate amount of starch and mix to make a total of 500g, put it into a capsule, and the capsule content is about 0.5g.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93107382 CN1080863A (en) | 1993-06-28 | 1993-06-28 | A kind of anti-alcoholic health care medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93107382 CN1080863A (en) | 1993-06-28 | 1993-06-28 | A kind of anti-alcoholic health care medicinal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1080863A true CN1080863A (en) | 1994-01-19 |
Family
ID=4986666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93107382 Pending CN1080863A (en) | 1993-06-28 | 1993-06-28 | A kind of anti-alcoholic health care medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1080863A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055211C (en) * | 1994-04-07 | 2000-08-09 | 任贵兴 | Antialcoholic liver-protecting preparation and its preparing method |
| US6399072B1 (en) * | 1996-03-13 | 2002-06-04 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of alcoholism |
| US6509381B2 (en) * | 1996-03-13 | 2003-01-21 | Archer Daniels Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions |
| CN103461871A (en) * | 2013-07-29 | 2013-12-25 | 安徽燕之坊食品有限公司 | Sobering-up foodstuff and preparation method thereof |
| CN111956713A (en) * | 2020-09-03 | 2020-11-20 | 华熙生物科技股份有限公司 | Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof |
| CN121059699A (en) * | 2025-10-31 | 2025-12-05 | 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) | Traditional Chinese medicine compositions, preparation methods, and applications with hangover-relieving and liver-protecting effects. |
-
1993
- 1993-06-28 CN CN 93107382 patent/CN1080863A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1055211C (en) * | 1994-04-07 | 2000-08-09 | 任贵兴 | Antialcoholic liver-protecting preparation and its preparing method |
| US6399072B1 (en) * | 1996-03-13 | 2002-06-04 | Archer Daniels Midland Company | Method of preparing and using isoflavones for the treatment of alcoholism |
| US6509381B2 (en) * | 1996-03-13 | 2003-01-21 | Archer Daniels Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions |
| US6518319B1 (en) * | 1996-03-13 | 2003-02-11 | Archer Daniels Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
| US6900240B2 (en) | 1996-03-13 | 2005-05-31 | Archer-Daniels-Midland Company | Method of preparing and using compositions extracted from vegetable matter for the treatment of cancer |
| CN103461871A (en) * | 2013-07-29 | 2013-12-25 | 安徽燕之坊食品有限公司 | Sobering-up foodstuff and preparation method thereof |
| CN111956713A (en) * | 2020-09-03 | 2020-11-20 | 华熙生物科技股份有限公司 | Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof |
| CN111956713B (en) * | 2020-09-03 | 2021-10-15 | 华熙生物科技股份有限公司 | Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof |
| CN121059699A (en) * | 2025-10-31 | 2025-12-05 | 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) | Traditional Chinese medicine compositions, preparation methods, and applications with hangover-relieving and liver-protecting effects. |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102100874A (en) | A kind of Chinese patent medicine for treating diabetes and preparation method thereof | |
| CN107412721B (en) | A kind of hypoglycemic bitter gourd polypeptide compound capsule and preparation method thereof | |
| CN100542584C (en) | Compound seabuckthorn buccal tablet and preparation method thereof | |
| CN102302673B (en) | Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN) | |
| CN110876772A (en) | Preparation method and application of traditional Chinese medicine preparation with liver protection function | |
| CN102614281A (en) | Chinese medicinal composition for improving anoxia endurance and preparation method and application thereof | |
| CN1080863A (en) | A kind of anti-alcoholic health care medicinal composition | |
| CN1292671C (en) | Method for producing tu-chung instant tea and its water drinking product | |
| CN107801990A (en) | A kind of health food of auxiliary hyperglycemic and preparation method thereof | |
| CN1080864A (en) | A kind of alcohol-decomposing powder and preparation method thereof | |
| CN111298021A (en) | Traditional Chinese medicine composition for treating functional constipation | |
| CN101642480A (en) | Pseudo-ginseng flower leaf oral tablet with function of reducing fever and preparation method thereof | |
| CN108977326A (en) | A kind of notoginsen flower wine and its preparation process | |
| CN108324803A (en) | Solid beverage of auxiliary hyperglycemic and preparation method thereof | |
| CN106106945A (en) | A kind of Ganoderma bagged infusion of American ginseng tea of enhancing immunity and preparation method thereof | |
| CN107595954A (en) | A traditional Chinese medicine composition for reducing body fat mass and treating abdominal obesity and its application | |
| CN113952419A (en) | Pharmaceutical composition for chronic renal failure and preparation method and application thereof | |
| CN101020016B (en) | Medicine for treating fracture and injured tendon and its preparation | |
| CN106177416B (en) | A kind of Chinese medicine composition for lowering blood sugar and preparation method thereof | |
| CN101011550A (en) | Medicinal composition for relieving stagnation, promoting circulation of qi and relieving pain, and its preparing process | |
| CN101147767B (en) | Preparation method of medicinal composition for treating acne | |
| LU600020B1 (en) | A traditional Chinese medicine composition for the treatment of alcoholic liver disease and its manufacturing process | |
| LU503014B1 (en) | BRAIN-TONIFYING GRANULES AND PREPARATION METHOD THEREOF | |
| CN114425066B (en) | Composition, medicine, food or health product for relieving physical fatigue and preparation method thereof | |
| CN102657699B (en) | Cane sugar-containing and sugar-free Shenkun blood nourishing granules with longer period of validity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |